Manhattan Scientifics

Manhattan Scientifics FCF per Share

Free Cash Flow per Share of Manhattan Scientifics (MHTX) as of Nov 11, 2026.

FCF per Share

-0.00USD

YoY

-45.56%

Last updated:

Free Cash Flow per Share of Manhattan Scientifics is 2023 -0.00 USD. Free Cash Flow per Share of Manhattan Scientifics was 2022 -0.00 USD. It decreases by -45.56% higher compared to the previous year.

The Manhattan Scientifics FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2016
-0.01 USD
Jan 1, 2017
-0.00 USD
Jan 1, 2018
-0.00 USD
Jan 1, 2019
-0.00 USD
Jan 1, 2020
-0.00 USD
Jan 1, 2021
-0.00 USD
Jan 1, 2022
-0.00 USD
Jan 1, 2023
-0.00 USD
The Manhattan Scientifics FCF per Share history
YEARFCF per ShareYoY
-0.00USD-45.56%
-0.00USD-17.10%
-0.00USD+7.40%
-0.00USD+22.17%
-0.00USD-55.36%
-0.00USD-14.14%
-0.00USD-82.52%
-0.01USD-245.63%
0.01USD-216.23%
-0.01USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Manhattan Scientifics Stock analysis

What does Manhattan Scientifics do? Manhattan Scientifics Inc is an innovative company that operates in the world of science and technology. The company was founded in 1994 by Marvin Maslow and is based in New York City. It primarily focuses on developing advanced technologies in the fields of materials science, biotechnology, and medical technology. The business model of Manhattan Scientifics Inc is based on the discovery and development of new technologies, which are then licensed or sold. The company specializes in technology development and works closely with scientific institutions and researchers around the world. In the past, the company has collaborated closely with NASA and the Los Alamos National Laboratory, and has been able to bring several successful products to market. The various divisions of Manhattan Scientifics Inc include nanotechnology, biotechnology, and medical technology. In the field of nanotechnology, the company has developed advanced technologies for the production of ultralight, highly strong materials. These materials are used in aerospace, construction, and other industries where lightweight and durable materials are needed. The biotechnology division of Manhattan Scientifics Inc focuses on the development of novel therapies for cancer and other diseases. The company has successfully developed a new cancer therapy based on magnetic nanoparticles. These nanoparticles are introduced into the body and attach to cancer cells. They are then attracted and killed by an external magnetic field. Medical technology is another important division of Manhattan Scientifics Inc. The company has developed advanced technologies for the production of medical devices that provide more precise surgeries and treatments. One of Manhattan Scientifics Inc's successful innovations is a device that can precisely target tumors with high-energy radiation to destroy them. Manhattan Scientifics Inc has brought several successful products to market in the past. One example of such a product is the Greenshift Corporation System, which helps reduce emissions from airplanes. The company has also had successful collaborations with NASA on various projects, including the development of super-lightweight carbon fiber components. Overall, Manhattan Scientifics Inc is an innovative company that specializes in the development of new technologies. The company has successfully worked in various fields, including nanotechnology, biotechnology, and medical technology. Its business model is based on the discovery and development of new technologies, which are then licensed or sold. Through its collaborations with scientific institutions and researchers around the world, the company has developed and brought several successful products to market. Manhattan Scientifics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Manhattan Scientifics stock

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Manhattan Scientifics since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Manhattan Scientifics

All Key Metrics — Manhattan Scientifics